Compare CMCL & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMCL | KRMD |
|---|---|---|
| Founded | 1992 | 1980 |
| Country | Jersey | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 373.1M | 192.5M |
| IPO Year | 2003 | 2019 |
| Metric | CMCL | KRMD |
|---|---|---|
| Price | $26.12 | $3.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $28.00 | $6.50 |
| AVG Volume (30 Days) | 163.6K | ★ 221.5K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.48% | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $41,127,366.00 |
| Revenue This Year | $38.54 | $20.32 |
| Revenue Next Year | N/A | $17.37 |
| P/E Ratio | $10.88 | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $15.85 | $3.12 |
| 52 Week High | $38.75 | $6.61 |
| Indicator | CMCL | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 72.01 | 30.87 |
| Support Level | $25.86 | N/A |
| Resistance Level | $26.98 | $4.23 |
| Average True Range (ATR) | 0.83 | 0.10 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 94.11 | 17.46 |
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. Its project includes Maligreen and Motapa.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.